Good MorningEquity markets are bracing for what could be disappointing economic news in the face of rising optimism that inflation has peaked. The data includes the 1st read of Q4 GDP on Thursday and the PCE price index on Friday. Both are expected to reveal underlying economic strength and could come hotter than expected. In this scenario, the fear of rising interest rates would peak again and likely bring the S&P 500 down. If not, the market may be able to extend the rally that began on the 1st of the year and end January on an up note.
The S&P 500 is at a critical juncture. It is above a key channel but below a pivotal resistance level that could continue to cap gains if no other catalysts emerge. The risk that seems to be ignored by many market watchers is that the outlook for S&P 500 earnings is in decline. In this light, the index may move higher in the near term, but any gains are subject to quick reversal as the market bias is still bearish. Featured: Ex-CIA Insider: “Prepare for a Mid-Term Meltdown” (Ad) 
|
Technology | |
A mini-rally in the world of semiconductors makes many on Wall Street sit up and take notice. After logging a horrible 2022 with its seemingly endless supply of bad news, there’s been a decent lift across the board, particularly with some. Advanced Micro Devices, Inc. (NASDAQ: AMD) is one su... Read the Full Story |
|
From Our Partners | | On July 17th, the House passed the GENIUS Act - and at least one prominent Trump ally is raising alarms. Rep. Marjorie Taylor Greene claims the bill contains 'the entire setup, groundwork and infrastructure to move from cash to digital currency.'
If the legislation becomes law, the implications for how Americans store and control their money could be significant. There may be a limited window to act before it takes effect. | | Learn what steps you can take to protect your wealth before this becomes law |
|
Medical | |
GSK plc (NYSE: GSK) is in the running with Moderna Inc. (NASDAQ: MRNA) and Pfizer (NYSE: PFE) to produce respiratory syncytial virus (RSV) vaccines, and analysts outside the company predict it could have a material impact on its topline revenues.
GSK was one of the first companies to announce a p... Read the Full Story |
|
Medical | |
Johnson & Johnson (NYSE: JNJ) and Abbott Laboratories (NYSE: ABT) are 2 of the more attractive Dividend Kings for today’s market. They offer relatively high yields and at least some value while projecting growth in 2023. This is an important factor to note because the outlook for earning... Read the Full Story |
|
From Our Partners | | As commodity prices rise and governments crack down on material fraud, SMX (Security Matters) PLC is building the verification infrastructure companies suddenly need. Using molecular-level markers embedded directly into plastics, metals, fuels, and textiles, SMX creates Digital Material Passports that track authenticity, recycled content, and lifecycle data from source to end use.
With recycled materials becoming cost-competitive and compliance rules tightening globally, SMX is positioned at the intersection of physical assets and digital verification - a rare small-cap with a specific solution for a fast-growing problem. | | See why SMX could be among the first small-caps to benefit from stricter material verification rules |
|
Technology | |
Cybersecurity stocks are down from their high-flying days in the post-pandemic world. Stocks from Palo Alto Networks (NASDAQ: PANW) to Datadog Inc. (NASDAQ: DDOG) and Paycom Software (NASDAQ: PAYC) are down 50% or more from those days, but the time to buy them might be at hand. Results from F5 Net... Read the Full Story |
|
Transportation | |
At least two (2) of America’s Class 1 railroads are pulling back into buying territory, which is good news for investors. These railroads are cash-generating machines that pay healthy dividends and buy back shares. The outlook for 2023 is a little cloudy but one thing is clear, capital retur... Read the Full Story |
|
From Our Partners | | Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge.
Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks.
Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. | | Watch Marc Chaikin's free presentation and get his full buy-and-sell list today |
|
Medical | |
Biotech Pliant Therapeutics Inc. (NASDAQ: PLRX) zoomed 34% higher on January 23 and added to that gain in the subsequent session.
The gap-up followed the company’s announcement of results for a treatment for a lung condition known as idiopathic pulmonary fibrosis.
Patients with this cond... Read the Full Story |
|
Medical | |
The 2023 calendar year has already been rocky for many biotech companies. Just three weeks into the new year, layoffs are already plaguing the industry. Of course, while layoffs may not be the most desirable outcome for those in the industry, they can be a boon for investors.
Among those who have... Read the Full Story |
|
Aerospace | |
Sending satellites into orbit with rockets already has an established track record, but small-cap Rocket Lab USA, Inc. (NASDAQ: RKLB) staged its first U.S. launch on January 24. The payload consisted of three small satellites.
The company went public in April 2021 via a merger with special purpos... Read the Full Story |
|
Markets | |
Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000. While the interim positive outcome is based on a 20-patient group, it expects to complete the phase 2 trial with 80 patients by the end of the first ... Read the Full Story |
|
Retail/Wholesale | |
It was supposed to be a rough year for retailers. You wouldn’t know it by their stock charts.
The National Retail Federation predicted that November and December sales would grow around 7%. As it turned out, inflation and higher interest rates had a bigger-than-expected impact on holiday sh... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Western New England Bancorp, Inc. operates as the holding company for Westfield Bank that provides a range of commercial and retail banking products and services to individuals and businesses. The company accepts various deposit accounts, including interest-bearing and noninterest-bearing checking, commercial checking, business, nonprofit and municipal checking, savings, money market and sweep, individual retirement, and other savings accounts; time deposits; certificates of deposit; and interest on lawyer's trust accounts. It also offers residential real estate loans, including first mortgages, home equity loans, and home equity lines, and secured by one-to-four family residential properties; commercial and industrial loans, such as letters of credit, revolving lines of credit, working capital, equipment financing, and term loans; commercial mortgage loans; construction and land development loans; home equity loans comprising home equity revolving loans and lines of credit; and consumer loans, including automobile, spa and pool, collateral, and personal lines of credit. In addition, the company provides automated teller machine (ATM), telephone and online banking, remote deposit capture, cash management, overdraft and safe deposit facility, and night deposit services. The company was formerly known as Westfield Financial, Inc. and changed its name to Western New England Bancorp, Inc. in October 2016. The company was founded in 1853 and is headquartered in Westfield, Massachusetts. | | View Today's Stock Pick |
|
